The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

2 Sep 2010 14:44

RNS Number : 0747S
PuriCore Plc
02 September 2010
 



PuriCore plc

(the "Company")

 

Director Dealing

 

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 2 September 2010 - PuriCore(LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces it has been informed that on 1 September 2010, Chris Wightman, Executive Chairman, transferred 132,075 shares to his SIPP at 53p per share.

 

Following this transaction, there is no change in Mr Wightman's beneficial interest in the Company. Mr Wightman remains interested in 178,810 Ordinary Shares of the Company representing 0.79% of the Company's current issued share capital with voting rights.

 

Enquiries:

Financial Dynamics

Susan Quigley

Ben Brewerton

+44 (0) 20 7831 3113

PuriCore

Chris Wightman

Executive Chairman

+44 (0) 20 7290 3440

 

 

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisation. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.

 

To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUGUPCBUPUGWP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.